Cargando…
Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome
Introduction. In advanced HIV prior to combination antiretroviral therapy (ART), dysplastic marrow changes occurred and resolved with ART. Few reports of myelodysplastic syndromes (MDS) in well-controlled HIV exist and management is undefined. Methods. Patients with well-controlled HIV and higher ri...
Autores principales: | Williamson, Bradley T., Leitch, Heather A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745308/ https://www.ncbi.nlm.nih.gov/pubmed/26904323 http://dx.doi.org/10.1155/2016/8502641 |
Ejemplares similares
-
Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome
por: Williamson, Bradley T., et al.
Publicado: (2016) -
Management of patients with lower-risk myelodysplastic syndromes
por: Brunner, Andrew M., et al.
Publicado: (2022) -
Myelodysplastic syndrome in patients living with HIV Infection
por: Boada, Matilde, et al.
Publicado: (2023) -
Cytogenetic features in myelodysplastic syndromes
por: Haase, Detlef
Publicado: (2008) -
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome
por: Sohn, Sang Kyun, et al.
Publicado: (2018)